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Abstract
The Sox family of transcription factors has been implicated in the development of different tissues during embryogenesis. Several
mutations in humans, mice, and zebrafish have shown that depletion of Sox10 activity produces defects in the development of neural crest
derivatives, such as melanocytes, ganglia of the peripheral nervous system, and some specific cell types as glia. We have isolated the
Xenopus homologue of the Sox10 gene. It is expressed in prospective neural crest and otic placode regions from the earliest stages of neural
crest specification and in migrating cranial and trunk neural crest cells. Loss-of-function experiments using morpholino antisense oligos
against Sox10 produce a loss of neural crest precursors and an enlargement of the surrounding neural plate and epidermis. This effect of
Sox10 depletion is produced during some of the earliest steps of neural crest specification, as is shown by the inhibition in the expression
of Slug and FoxD3, which are early markers of neural crest specification. In addition, we show that Sox10 depletion leads to an increase
in apoptosis and a decrease in cell proliferation in the neural folds, suggesting that Sox10 could work as a survival as well as a specification
factor in neural crest precursors during premigratory stages. Although some of the deficiencies found in the Waardenburg syndrome and in
the Hirschprung disease could be associated with a failure of the development of crest derivatives during the late phase of its development,
or even during adulthood, our results suggest that inhibition of Sox10 activity produces an earlier failure of neural crest precursors. In
experiments where melanocytes and ganglia were induced in vivo and in vitro, we were able to block their development by inhibiting Sox10
activity. These results are compatible with an additional late role of Sox10 on development of neural crest derivatives, as it has been
previously proposed. We show that Sox10 expression is dependent on FGF and Wnt activity, both in the neural crest and in the otic placode
territories. Finally, in order to establish the position of Sox10 in the hierarchical cascade of gene activation required for neural crest
specification, we used inducible forms of the wild type and dominant negatives for the Snail and Slug genes. Our results show that Snail
is able to control Sox10 expression. However, the overexpression of Slug was not able to upregulate Sox10 expression. Taken together, these
results indicate that Sox10 may lie between Snail and Slug in the genetic cascade that controls neural crest development.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The neural crest comprises a unique set of cells, which
segregate from the dorsal part of the neural tube and un-
dergo extensive and coordinated movements, giving rise to
numerous and diverse cell types, including the craniofacial
skeleton, much of the peripheral nervous system, and pig-
ment cells (for reviews on neural crest development, see
LaBonne and Bronner-Fraser, 1999; Mayor et al., 1999).
The cellular and molecular mechanisms that control neural
crest induction, migration, and differentiation are now be-
ginning to be unraveled. Signals emanating from the epi-
dermis, the axial, and paraxial mesoderm are believed to be
involved in the specification of the neural crest (Selleck and
Bronner-Fraser, 1995; Mancilla and Mayor, 1996; Bonstein
et al., 1998; Marchant et al., 1998). Several molecules have
been involved in the process of neural crest induction (for a
review, see Aybar and Mayor, 2002; Aybar et al., 2002). It
has been shown in Xenopus and zebrafish that a threshold
level of BMP activity is required to specify neural crest
(Morgan and Sargent, 1997; Marchant et al., 1998; Nguyen
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Fig. 1. Sequence and structure of Xenopus Sox10. (A) Deduced amino acid sequences from human, rat, and Xenopus Sox10 were aligned by using the
ClustalW algorithm. Identical and similar amino acids are in black and gray boxes, respectively. The HMG box is underlined in red, and the putative
transactivation domain in blue. (B) Phylogenetic unrooted tree, including different Sox9 and Sox10 members as well as the Xenopus Sox4 protein, clearly
shows that Xenopus Sox10 is closely related to the proteins of the Sox10 family. Xenopus Sox4 branch is collapsed 50%.
Fig. 2. Expression pattern of Sox10 during development by whole-mount in situ hybridization. (C–J, N–S) Sox10 expression; (A, K, L) Slug expression; (B,
M) Sox9 expression. (A–C) Early neurula stage showing the expression of Slug (A), Sox9 (B), and Sox10 (C). Note the main expression in the prospective
neural crest for the three genes, and the expression in the prospective otic placode for Sox9 and Sox10 (arrowhead, higher magnifications in E and F,
respectively). (D) Sox10 expression at the midneurula stage, showing the expression in the prospective cephalic (section in G) and trunk (section in H) neural
crest. (I) Late neurula stage showing the expression in the trunk (tnc) and cephalic (cnc). (J, K) Comparison in the expression pattern of Sox10 and Slug in
the hindbrain region of a late neurula-stage embryo. While the expression of Sox10 is homogeneous in the hindbrain (J, arrow), the expression of Slug is absent
from rhombomeres 3 and 5 (K, arrows). Arrowhead in (J) indicates the otic vesicle. (L–N) Comparison in the expression of Slug (L), Sox9 (M), and Sox10
(N) during migration of the cephalic neural crest. Mandibular (m), Hyoid (h), and branchial (b) streams show expression of the three markers. Arrowhead,
otic vesicle; asterisk, optic vesicle. (P–S) Tailbud-stage embryo showing expression in the melanocytes (P, arrows), otic vesicle (Q, arrowhead), and in the
crest migrating into the dorsal fin (S). (R) Section through the otic vesicle of a late neurula-stage embryos showing the expression of Sox10.
et al., 1998). It has been shown that FGF, Wnts, and retinoic
acid are also involved in neural crest induction (Mayor et
al., 1995, 1997; LaBonne and Bronner-Fraser, 1998; Saint-
Jeannet et al., 1997; Bang et al., 1999; Deardorff et al.,
2002; Dorsky et al., 1998; Villanueva et al., 2002).
In Xenopus, several genes that code for transcription
factors have been found to be expressed in the neural crest
(for a review, see Mayor and Aybar, 2001; Aybar et al.,
2002), including Snail (Mayor et al., 1993; Essex et al.,
1993; Linker et al., 2000), Slug (Mayor et al., 1995), Zic5
(Nakata et al., 2000), Foxd3 (Dirkensen and Jamrich, 1995),
and Twist (Hopwood et al., 1989). Although the hierarchical
relationship between these transcription factors has not been
established, it has been shown that Snail is the only gene
able to trigger the expression of all other neural crest genes
in absence of neural plate markers; thus, Snail seems to lie
furthest upstream in the genetic cascade of neural crest
development (Aybar et al., 2003).
Sox transcription factor genes are found in all metazoan
species and play key roles in embryonic development (for a
review, see Wilson and Koopman, 2002). There are about
20 different Sox genes (Bowles et al., 2000). They are
characterized by the presence of an HMG-box, a sequence
specific DNA-binding domain (Pevney and Lovell-Badge,
1997; Wegner, 1999). Two members of this family have
been involved in neural crest development: Sox9 and Sox10.
Sox9 has been shown to regulate cartilage formation by
direct binding to the enhancer of type II collagen (Bell et al.,
1997; Bi et al., 1999). During mouse, Xenopus, and ze-
brafish development, Sox9 is expressed in neural crest pro-
genitors (Zhao et al., 1997; Ng et al., 1997; Spokony et al.,
2002; Chiang et al., 2001; Li et al., 2002). Loss-of-function
experiments in Xenopus show that Sox9 is required for the
development of the cranial neural crest (Spokony et al.,
2002). Heterozygous mutations of Sox9 result in Cam-
pomelic Dysplasia (CD), a lethal human disorder character-
ized by autosomal XY sex reversal and severe skeletal
malformations (Houston et al., 1983; Wagner et al., 1994).
Mutations in the Sox10 gene are associated with the neuro-
cristopathy syndromes Waardenburg–Hirschprung and Ye-
menite deaf–blind hypopigmentation (Wagner et al., 1994;
Foster et al., 1994; Berta et al., 1990; Ja¨ger et al., 1990;
Pingault et al., 1998; Bonduran et al., 1999; Sham et al.,
2001). Those conditions are associated with intestinal agan-
glionosis and depigmentation with deafness. In the sponta-
neous mouse mutant Dominant megacolon (Dom), Sox10
carries a frameshift mutation (Southard-Smith et al., 1998;
Herbarth et al., 1998). Mutant mice suffer from several
neural crest defects in which the homozygous animals are
characterized by a loss of neurons and glia in the peripheral
nervous system, a complete lack of the enteric nervous
system, and absence of melanocytes. It has been shown that
Sox10 is directly related to glial development and to the
terminal differentiation of myelin-forming oligodendrocytes
(Britsh et al., 2001; Stolt et al., 2002). Target genes of Sox10
include genes important for glial development (ErbB3) and
identity, such as the genes for the myelin proteins Protein
Zero (P0), Myelin Basic Protein, and Proteolipid Protein
(Britsh et al., 2001; Peirano et al., 2000; Stolt et al., 2002).
The Sox10 mutant has been identified in zebrafish as a
mutation in the colourless locus (cls), which exhibits loss of
pigment cells and enteric nervous system, together with
large reductions in sensory and sympathetic neurons and
putative satellite glia and Schwann cells (Kelsh et al., 2000;
Kelsh and Eisen, 2000). Thus, it seems to be clear that
Sox10 is required for the development of specific neural
crest derivatives in different species, such as cells of the
peripheral nervous system and melanocytes, both tissues
that originate from trunk neural crest. The identification of
target genes for Sox10 and its expression at late stages of
development in some of the neural crest derivatives sug-
gests that Sox10 is required for the specification of partic-
ular subset of neural crest cells at the postmigratory stage, as
no role for Sox10 during the premigratory stage of the
neural crest has been shown. It has been proposed that
during embryogenesis a limited number of Sox proteins,
differentially expressed in the developing neural crest, are
required for the specification and differentiation of subsets
of neural crest derivatives as they emerge along the antero-
posterior axis, being Sox9 and Sox10 involved in cephalic
and trunk neural crest, respectively (Spokony et al., 2002).
This hypothesis has not been tested.
In order to investigate the function that Sox10 could have
in neural crest development in Xenopus embryos, we iso-
lated it and performed functional analyses. Loss-of-function
experiments show that Sox10 is involved in the early spec-
ification of the neural crest precursors as well as in the
survival of those cells. These results allow to propose a new
early function of Sox10 that could explain some of the
phenotypes produced by the Sox10 mutations in humans.
We also show that Sox10 expression is induced by FGF and
Wnt signaling and that it lies in between the Snail and Slug
genes in the genetic cascade that controls neural crest de-
velopment.
Materials and methods
Embryonic manipulation and blocking FGF activity
Embryos were obtained from adult Xenopus laevis by
standard hormone-induced egg laying and artificial fertili-
zation (Villanueva et al., 2002). Embryos were staged ac-
cording to Nieuwkoop and Faber (1967), and dissections
were carried out by using eyebrow knives as indicated in
Mancilla and Mayor (1996).
To block FGF activity, the inhibitor SU5402 (Calbio-
chem) was used. Resin beads (AG1- X2) were incubated
overnight with 0.5 mM of SU5402 in PBS and grafted next
to the prospective neural crest of a stage 12 embryo.
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Isolation of Xenopus Sox10 homologue
In order to isolate the X. laevis Sox10 homologue, we
performed a silico approach. The NCBI database was
screened by using high stringency Tblastx against a pool of
X. laevis expressed sequence tags (ESTs) constructed from
approximately 40 different X. laevis embryonic libraries
containing around 230,000 ESTs. We used the sequence of
the human Sox10 mRNA (Accession No. AJ001183) as a
probe, and we identified several interesting ESTs. The three
highest E-values obtained were 2e-71, 2e-53, and 2e-46,
corresponding to clones XL053o11, XL090e13, and
XL094d15 from the NIBB Mochii normalized Xenopus
tailbud library (EST Accession Nos. BJ069596, BJ074478,
and BJ071385, respectively). The 2818-bp-length clone
XL053o11, kindly provided by Dr. Naoto Ueno (NIBB,
Okazaki, Japan), was fully sequenced in both directions
revealing an open frame for Xenopus Sox10 protein and was
deposited in GenBank (AY157667), while the clone
XL094d15 was identical to the sequence reported for Xe-
nopus Sox9 (Spokony et al., 2002).
Alignments of amino acid sequences were done by using
the ClustalW algorithm (http://www.ebi.ac.uk/clustalw/in-
dex.html). The Accession Nos. of the aligned genes are rat
Sox10 NM_019193, mouse Sox10 AF047043, human Sox10
AJ001183, chicken Sox10 AF152356, and zebrafish Sox10
NM_131875. The phylogenetic tree was drawn with the
Phylodendron application (http://iubio.bio.indiana.edu/
treeapp/treeprint-form.html) from data generated with
ClustalW. Additional Accession Nos. of Sox proteins are
AY035397, AF421878, U12533, AF277096, AF277097,
Z46629, and AF186844.
Morpholino antisense oligonucleotide and Sox10
contructs
A morpholino antisense oligonucleotide (mo) was de-
signed against the 5UTR of Xenopus Sox10 adjacent to the
initiation start site with the following base sequence 5-
AGCTTTGGTCATCACTCATGGTGCC-3 (Gene Tools,
LLC). Doses of 1-12 ng/embryo were microinjected to-
gether with a lineage tracer into one blastomere at the two-
or four-cell stage. A control antisense oligonucleotide com-
posed of a random sequence designed by Gene Tools, LLC,
was injected as a control at the same concentrations.
In order to show the specificity of the morpholino used,
we performed rescue experiments coinjecting several forms
of the Sox10 RNA. One of the RNA injected contained the
full coding sequence, but the 5 morpholino target sequence
was mutated to avoid titration of the morpholino by the
RNA. Care was taken to mutate this sequence for one that
codes for the wild type Sox10 amino acid sequence. This
construct was named Sox10* and was made by amplifying
the coding sequences by PCR with a high-fidelity polymer-
ase (Roche Molecular Biochemical, Mannheim, Germany)
using the following primers: 5-GAATTCATGTCTGACG-
ATCAGTCTTTGTCCGAAGTAGAG-3 and 5-GGTAC-
CATGGTCTTGAAAGTGTAGTATAGACTG-3.
The PCR products were purified and cloned into
pGEM-T Easy vector (Promega). The constructs were au-
tomatically sequenced on both strands at the junctions
(BRC, Cornell University, Ithaca, NY, USA).
RNA microinjection, lineage tracing, and dexamethasone
induction
Dejellied embryos were placed in 10% NAM containing
5% Ficoll and one blastomere of two-cell-stage embryos
was injected with differing amounts of capped mRNA con-
taining 1–3 g/l lysine-fixable fluorescein dextran (40,000
MW; FDX, Molecular Probes) as a lineage tracer.
The wild type Snail and Slug and dominant negatives of
Snail and Slug used are described in Aybar et al. (2003). For
the inducible constructs, ethanol-dissolved Dexamethasone
(10 M) was added to the culture medium at stage 12.5 or
16 and maintained until the embryos were fixed. To control
the possible leakage of inducible chimeras, a sibling batch
of embryos was cultured without Dexamethasone and pro-
cessed for in situ hybridization.
In situ hybridisation, TUNEL and immunohistochemistry
Antisense probes containing Digoxigenin-11-UTP
(Roche Biochemicals) were prepared for Sox10 (digested
with SmaI, from pBluescript vector), Sox9 (digested with
HindII, from pBluescript vector), Xtwist (Hopwood et al.,
1989), Sox-2 (Dr. R.M. Grainger, personal communication),
Krox20 (Bradley et al., 1993), cytokeratin Xk81A (Jo¨nas et
al., 1985), Slug (Mayor et al., 1995), Snail (Essex et al.,
1993), and FoxD3 (Sasai et al., 2001) by in vitro transcrip-
tion. Specimens were prepared, hybridized, and stained ac-
cording to Harland (1991) with the modifications described
in Mancilla and Mayor (1996). Detection of labeled anti-
sense probes was performed by using alkaline-phosphatase-
conjugated anti-digoxigenin Fab fragments (Roche Bio-
chemicals) and with NBT/BCIP (purple) as substrate. Lin-
eage tracer was detected as described in Aybar et al. (2003).
Apoptosis was detected by TUNEL staining according to
the procedure described in Hensey and Gautier (1998).
Rabbit polyclonal anti-phosphohistone-3 from Upstate Bio-
technology was used to analyze mitotic cells according to
the method described by Turner and Weintraub (1994).
RNA isolation and RT-PCR analysis
Total RNA was isolated from embryonic tissue by the
guanidine thiocyanate/phenol/chloroform method (Chom-
czynski and Sacchi, 1987), and cDNAs were synthesized by
using AMV reverse transcriptase (Roche Biochemicals) and
oligo(dT) primer. Primers for Xsnail, Xtwist, and H4 were
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described in Aybar et al. (2003). The primers designed for
this study were: XSox10 primers (from AY157667): 5-GT-
CCTGGAGAGCAATATGCTCCAG-3 and 5-CCATTG-
TACTGTGAACACAGCATGC-3; XMitf- primers (from
Dr. Mayuko Kumasaka, personal communication): 5-GG-
AGCTAGAGATGCAAGCACG-3 and 5-ACTCTCGGA-
GAAAGTGTATCGTCC-3; c-kit primers (from Z48770,
Xenopus c-kit related kinase 1): 5-CGCAGACATTGAGT-
CCGAGG-3 and 5-CAGAATGTCTTGCAGCATTGGG-
3; c-ret (from AF286643): 5-CATCCACTCCTGCT-
GACTCC-3 and 5-CAAACATCTGCAGATGCTGCC-3
PCR amplification with these primers was performed
over 29 cycles (Xsnail, Xtwist, and H4) and 32 cycles
(Xmitf, c-kit, c-ret, and Sox10), and the PCR products were
analyzed on 1.5% agarose gels. As a control, PCR was
performed with RNA that had not been reverse-transcribed
to check for DNA contamination.
Results
Isolation of Xenopus Sox10 homologue
By performing a homology search in the EST databases
at NCBI using the human Sox10 cDNA sequence, we iden-
tified a Xenopus Sox10 homologue. The in silico screen
yielded one clone (XL053o11) originated from a tailbud-
stage library with an E-value of 3e-71. The complete se-
quence was deposited in GenBank (Accession No.
AY157667) and revealed that encodes the entire open read-
ing frame of 446 amino acids of the Sox10 protein (Fig.
1A). The conserved domain search with the RPS-Blast and
CDART utilities indicated that this protein has a character-
istic HMG (high mobility group) box from residues 98 to
166. We have localized a putative transactivation (TA)
domain of Sox10 to the C terminus of the protein. It is very
similar in position, size, and composition to TA domain of
other Sox proteins (i.e., 85% vs. human Sox10; Pusch et al.,
1998) spanning residues 358-446. When we compared the
entire amino acid sequence, we found that Sox10 shares
71% identity with human, rat, and mouse Sox10, 77% with
chicken Sox10, and 61% with zebrafish Sox10. When com-
pared with Sox4, amino acid identity decreases to 26%.
Sox10 proteins fall into subgroup E that also includes Sox8
and Sox9 proteins (Kamachi et al., 2000; Bell et al., 2000;
Pusch et al., 1998). A phylogenetic unrooted tree including
different Sox9 and Sox10 members as well as the Xenopus
Sox4 protein sequence clearly indicates that Xenopus Sox10
is closely related to the proteins of Sox10 family (Fig. 1B).
Sox10 is expressed in the neural crest and in the otic
placode
In order to analyze the spatial expression pattern of
Sox10, we performed whole-mount in situ hybridization on
a variety of embryonic stages and compared the expression
of Sox10 with the expression pattern of Sox9 and Slug, two
known neural crest markers. A low level of Sox10 expres-
sion can be detected at the early gastrula stage, but in a
nonlocalized pattern (not shown). The first localized expres-
sion of Sox10 can be observed at stage 12–12.5 as a weak
stain in the prospective neural crest. At stage 15, strong
expression is observed in neural crest cells (Fig. 2C), which
is very similar to the expression of the neural crest marker
Slug (Fig. 2A; Mayor et al., 1995) and to the related Sox
gene Sox9 (Fig. 2B; Spokony et al., 2002). In addition to the
neural crest expression, Sox10 can also be detected in the
prospective otic placode, similar to the expression of Sox9
(arrowhead in Fig. 2B and C). The expression of Sox10 in
Fig. 3. Sox10 morpholino inhibits Slug expression in a dose-dependent
manner. (A) Embryos were injected in one blastomere of a two-cell-stage
embryo with different concentrations of moSox10 or with CmoSox10 and
analyzed for Slug expression by whole-mount in situ hybridization at stage
16 (A). The injected side is shown to the right, adapted from Nieuwkoop
and Faber (1967). (B) Representative embryo injected with CmoSox10. (C)
Representative embryo injected with 7 ng of moSox10. (D) Quantification
of Slug expression in the embryos injected with moSox10 (blue circles) or
CmoSox10 (red triangles). The number of embyos analyzed for 1, 5, and
7 ng was above 50, and for 8.5 and 10 ng was above 15. The amount used
in all the other experiments was 7 ng of moSox10 or 7 ng/embryo of
CmoSox10. Embryos with noticeable reduced or absent expression of Slug
were counted and are expressed as a percentage of total analyzed embryos.
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Fig. 4. The effect of Sox10 morpholino on Slug expression can be specifically rescued by coinjection of Sox10 mRNA. Embryos were injected in one
blastomere at the two-cell stage with different combinations of moSox10 and different forms of Sox10 or GFP mRNA, and the expression of Slug was
analyzed by in situ hybridization. (A) Representative embryo injected with Sox10 mRNA. Note the expanison of Slug in the injected side. (B) Representative
embryo injected with Sox10* mRNA. Note the expansion of Slug expression. (C) Representative embryo injected with moSox10. Note the inhibition of Slug
expression in the injected side. (D) Representative embryo coinjected with Sox10 mRNA and moSox10. Note the rescue in Slug expression. (E)
Representative embryo coinjected with Sox10* mRNA and moSox10. Note the rescue in Slug expression. (F) Representative embryo injected with moSox10
and GFP mRNA. Note that no rescue in the expression of Slug was observed (G) Quantification of the rescue on Slug expression. The rescue of Slug
expression was calculated as the difference in the effect of Slug inhibition produced by the moSox 10 and the effect produced by moSox 10Sox10 (Sox10*
or GFP) mRNA, divided by the effect produced by moSox 10 and expressed as percentages. Gray bar: rescue by Sox10 mRNA; black bar: rescue by Sox10*
mRNA; green bar: rescue by GFP mRNA. Two different concentrations of moSox 10 and Sox10 or Sox10* mRNA were used. Arrow, injected side; n 
number of embryos analyzed.
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the prospective otic placode seems to be weaker than the
expression of Sox9 (Fig. 2E and F). At the mid and late
neurula stage (17 and 23 in Fig. 2D and I, respectively), the
expression of Sox10 can be detected in cephalic (Fig. 2G)
and trunk (Fig. 2H) neural crest. Once the neural tube is
closed and the neural crest starts to migrate to the lateral and
ventral pathways, some of the cephalic neural crest also
migrates toward the dorsal pathway covering the most dor-
sal region of the anterior neural tube (Davidson and Keller,
1999; Linker et al., 2000). These neural crest cells express
Sox10 (Fig. 2J, arrow) and Slug (Fig. 2K); however, while
the expression of Sox10 can be observed as a continuous
layer of cells covering the hindbrain, the expression of Slug
is not detected in rhombomeres 3 and 5 (Mayor et al., 1995;
Fig. 2K, arrows). After stage 23, when the cephalic crest
cells are migrating, Slug, Sox9, and Sox10 can be observed
in the mandibular, hyoid, and branchial streams of the
migrating cephalic neural crest (Fig. 2L and M). In addition,
Sox9 is expressed in the optic vesicle (Fig. 2M, asterisk),
and Sox9 and Sox10 are expressed in the otic vesicle (Fig.
2M and N, arrowhead). The expression of Sox10 in the otic
vesicle and in the migratory neural crest continues at the
tailbud stage (Fig. 2O–S, section in R), where the migration
in the dorsal fin can be observed (Fig. 2S). Interestingly, at
this stage, a clear expression of Sox10 can be observed in
migrating melanocytes (Fig. 2O and P). Thus, Sox10 is
expressed in the premigratory, migratory, cephalic and
trunk, neural crest, and the otic placode.
Inhibition of Sox10 function blocks early formation of
neural crest cells
In order to investigate Sox10 function during neural crest
development, we performed loss- of-function studies using
morpholino antisense oligonucleotides (Heasman et al.,
2000). A morpholino antisense oligonucleotide was de-
signed against the 5UTR of Xenopus Sox10 adjacent to the
initiation start (moSox10). Embryos were injected at the
two- or four-cell stage in one-half of the embryo with 1–10
ng of moSox10 or an equivalent amount of a control mor-
pholino composed of a random sequence (CmoSox10) to-
gether with FLDx as a lineage tracer (Fig. 3A). At the early
neurula stage, the embryos were fixed and the expression of
the early neural crest marker Slug was analyzed. Embryos
injected with CmoSox10 showed a normal morphology and
expression of Slug (Fig. 3B and D), while embryos injected
with moSox10 failed to form a neural fold and exhibited a
clear inhibition of Slug expression on the injected side (Fig.
3C). Upon injection of 10 ng of moSox10, about 50% of the
injected embryos showed a reduction or complete loss of
Slug expression in the injected side, while this effect was
reduced when a lower amount of moSox10 was injected
(Fig. 3D). Thus, moSox10 blocks Slug expression in a
dose-dependent manner. We should mention that, for most
of our experiments, we used 7 ng of moSox10, as higher
concentrations were toxic to the embryos, specially when
they were analyzed at more advanced stages.
In order to show that the effect of moSox10 injection was
specific in blocking Sox10 activity, we performed two kind
of rescue experiments. First, 35% of the embryos injected
with Sox10 mRNA show a slight expansion in neural crest
markers, such as Slug in the injected side (Fig. 4A; n  59),
while, as we recently described, 38% of the embryos in-
jected with moSox10 (7 ng) exhibited an inhibition of Slug
expression in the injected side (Fig. 4C; n  68). However,
when embryos were injected with a combination of Sox10
mRNA and moSox10, a strong rescue in the expression of
Slug was observed (Fig. 4D and G; between 60 and 86% of
rescue in Slug expression, depending on the concentration
of morpholino and mRNA used). Second, as the Sox10
mRNA contains the morpholino target sequence, it is pos-
sible to argue that the injected RNA could titrate the mor-
pholino. In order to solve this problem, we made a new
Sox10 construct, named Sox10*, in which the morpholino
target sequence was mutated to avoid hybridization between
the injected RNA and the morpholino; we took care to
change the codon sequence without changing the amino
acids. Injection of Sox10* mRNA shows an expansion of
Slug expression in about 34% of the embryos (Fig. 4B; n 
50), showing that Sox10 activity was not affected by the
introduced mutations. However, when moSox10, which in-
hibits Slug expression, was coinjected with Sox10* mRNA,
a strong rescue in Slug expression was observed (Fig. 4E
and G; above 68% of rescue, depending on the amount of
Sox10* mRNA coinjected). We also show that this rescue of
the morpholino phenotype was specifically produced by the
coinjection of Sox10 mRNA, but not by the coinjection of
an unrelated mRNA, as the mRNA that codes for GFP was
unable to rescue the expression of Slug in moSox10-injected
embryos (Fig. 4F and G). Thus, we concluded that moSox10
was specifically affecting Sox10 activity.
To further analyze the phenotype of the moSox10-in-
jected embryos, we examined the expression of five other
genes that are expressed in the neural crest cells: Snail
(Mayor et al., 1993; Essex et al., 1993; Linker et al., 2000);
FoxD3 (Dirksen and Jamrich, 1995; Sasai et al., 2001);
Twist (Hopwood et al., 1989); Sox9 (Spokony et al., 2002),
Krox20 (Bradley et al., 1993), as well as the expression of
neural plate markers, such as Sox2 (R. Grainger, personal
communication), and epidermal markers, such as cytokera-
tin Xk81A (Jonas et al., 1989). Embryos were injected in one
blastomere at the two-cell stage (Fig. 5A) and cultured until
neurula stage, and the expression of the markers was ana-
lyzed. We observed a strong inhibition in the expression of
the neural crest markers Slug, FoxD3, and Sox9 [Fig. 5B–D;
38% (n  56), 35% (n  42); 33% (n  38) of embryos
with gene inhibition, respectively], and a slightly weaker
inhibition in the expression of Twist, Snail, and Krox20 (not
shown). In contrast to the inhibition in the expression of
neural crest markers, the neural plate was strongly ex-
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panded, while the expression of the epidermal markers
was weakly expanded in the moSox 10-injected side [Fig.
5E and F; 48% (n  38) and 41% (n  35) embryos with
Sox2 and K81A expansion, respectively]. The expression
of all these markers was analyzed at the open neural plate
stage. The effect on epidermal markers could be a con-
sequence of the absence of neural crest at the border of
the epidermis, as no overlapping of neural plate and
epidermis was observed. These results show that Sox10
depletion leads to a specific loss of neural crest progen-
itors at expenses of the surrounding neural plate, thus
suggesting that Sox10 is involved in the early specifica-
tion of the neural crest cells.
To understand the cellular mechanisms by which Sox10
produces the observed effects, we analyzed the effect that
Sox10 depletion had on apoptosis and on cell proliferation.
It has been described that the neural ectoderm, especially
the neural folds, has a higher level of apoptosis than the rest
of the ectoderm (Hensey and Gautier, 1998; C. Tribulo,
M.J.A., and R.M., unpublished results). Embryos were in-
jected in one blastomere of a two-cell-stage embryo with 7
ng of moSox10 mRNA and apoptosis was analyzed by
TUNEL staining. A clear increase in the number of cells
stained by TUNEL was observed in the injected side of the
embryos (Fig. 5G–I; 33% of embryos with increase in
TUNEL staining, n  31), while no effect was observed by
injection of CmoSox10. Cell proliferation was assessed by
the detection of a phosphorylated form of H3 histone. It is
known that the neural plate and particularly the neural folds
have a higher rate of cell proliferation than the rest of the
ectoderm (N. Papalopulu, personal communication). In or-
der to analyze the effect of moSox10 on cell proliferation in
the neural folds, we developed the staining of H3 only until
the staining of the fold was visible. We observed that
moSox10 produced a dramatic reduction of the labeling
with H3 in the injected side (Fig. 5J–L, 55% of embryos
with reduced H3 staining, n  25).
In order to test the ability of Sox10 to control neural crest
specification, we injected Sox10 mRNA at the two-cell
stage, and the expression of several markers was analyzed
by in situ hybridization. The injection of Sox10 mRNA
leads to a moderate expansion in the neural crest territory
analyzed by the expression of Slug and Sox9 [Fig. 6A and C;
25% (n  31) and 28% (n  25) of embryos with expansion
in gene expression, respectively]. Injection of Sox10 mRNA
also leads to a slight mediolateral reduction of the neural
plate, as analyzed by Sox2 expression (Fig. 6B, 28% re-
duced, n  35). A small expansion was also observed in the
expression of Krox20, within the domain from where neural
crest cells are generated (Fig. 6D, arrowhead); the normal
expression of Krox20 in rhombomeres 3 and 5 indicates that
Sox10 overexpression does not affect the anteroposterior
axis of the neural plate.
Inhibition of Sox10 blocks development of neural crest
derivatives
Our results show that moSox10 blocks the expression
of several early neural crest markers, but it is not known
whether the neural crest derived from these marker-
expressing cells is also affected. In order to test whether
the Sox10-depleted embryos lack neural crest derivatives,
the expression of several late markers of the melanogenic
and gangliogenic lineage, as well as the direct observa-
tion of melanocytes, was performed. First, we induced
neural crest in vitro (LaBonne and Bronner-Fraser, 1998)
by conjugating animal caps taken from embryos injected
with noggin and with Wnt5 mRNAs. Caps were cultured
in vitro and the expression of several markers was ana-
lyzed by RT-PCR (Fig. 7A). In a control experiment, we
observed the induction of early (Twist, Snail, and Sox10)
and late neural crest markers (Mitf, c-kit, and c-ret) in the
conjugate (Fig. 7B). Mitf and c-kit genes are expressed in
the melanogenic lineage, and c-ret is expressed in the
ganglia of the peripheral nervous system; both kinds of
cells are derived from trunk neural crest. When the ani-
mal caps were taken from embryos injected with
moSox10, normal expression of the early markers was
observed (Twist, Snail, Sox10), while no expression of
the late markers was detected (Mitf, c-kit, c-ret) (Fig.
7C). The control animal cap, with or without moSox10,
never showed the expression of any neural crest marker.
These results indicate that the melanogenic and ganglio-
genic lineages require intact Sox10 activity to differenti-
ate properly. Thus, we decided to look directly for the
presence of melanocytes in the moSox10-injected em-
bryos. Embryos were injected in both blastomeres at the
two- cell stage with 7 ng of moSox10, cultured until stage
38, and the melanocytes were analyzed. Control embryos
show a characteristic pattern of melanocytes (Fig. 7D,
arrow and inset; 100% of embryos showed melanocytes,
n  33), while moSox10-injected embryos exhibited a
reduction or an almost complete absence of melanocytes
(Fig. 7E; 45% of embryos with a reduction on melano-
cytes, n  44). The percentage of embryos with absence
of melanocytes was lower than the loss of the neural crest
markers. A possible explanation for this difference is that
the effect of the morpholino could not last until the stage
when the melanocytes are analyzed, or alternatively, the
initially lost neural crest could be regenerated from an-
other tissue. A second experiment to analyze the depen-
dence of melanocyte development on Sox10 activity was
performed. Melanocytes were induced in vitro (Bonstein
et al., 1998) by conjugating animal caps taken from stage
10 embryos with the prospective paraxial mesoderm
taken from an early gastrula embryos; the conjugates
were cultured until the equivalent of stage 35 and the
presence of melanocytes was analyzed (Fig. 7F). Control
animal caps exhibited the presence of typical melano-
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cytes recognized by the dark pigments in about 44% of
the conjugates (Fig. 7G, n  9), while the conjugates that
contain moSox10 in the animal cap showed no melano-
cyte formation (Fig. 7H, n  7). Taken together, our
results indicate that Sox10 activity is required for the
normal development of melanogenic cells.
Fig. 6. Overexpression of Sox10 leads to an increase in neural crest markers. Embryos were injected in one blastomere at the two-cell stage with 2 ng of Sox
10 mRNA, and the expression of several markers was analyzed by in situ hybridization. Arrow, injected side. (A) Slug expression. Note an enlargement of
the Slug-expressing territory in the injected side. (B) Sox2 expression. Note a reduction in its expression in the injected side. (C) Sox9 expression. Note an
expansion of Sox9 in the injected side. (D) Krox20 expression. Note a small expansion in the neural crest derived from rhombomere 5 that expresses Krox20
(arrowhead).
Fig. 5. Sox10 depletion leads to a loss in neural crest markers, an increase in apoptosis, and an inhibition in cell proliferation. (A) Embryos were injected in one
blastomere at the two-cell stage with 7 ng of moSox 10, and the expression of several markers was analyzed by in situ hybridization, the apoptotic cells by TUNEL
staining, or the dividing cells by phosphoH3 inmunostaining. Arrow indicates the injected side. (B) Slug expression. (C) FoxD3 expression. (D) Sox9 expression.
Note the inhibition in the expression of these three neural crest markers. (E) Sox2 expression. Note the expansion in the expression of this neural plate marker. (F)
Cytokeratin K81A expression. Note the weak expansion in the expression of this epidermal marker. (G–I) TUNEL staining. (G) Note the increase in the apoptotic
cells in the injected side. Higher magnification of the uninjected (H) and injected (J) side of the same embryo, showing a higher level of apoptosis in the injected
side. (J–L) Phospho H3 staining of embryo injected with 10 ng of moSox10. (J) Note the inhibition in phospho H3 staining in the injected side. Higher magnification
of the uninjected (K) and injected (L) side of the same embryo, showing a dramatic reduction in cell proliferation in the moSox 10-injected side.
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Regulation of Sox10 expression by inductive signals and
transcription factors
Several molecules have been identified as neural crest
inducers, among them are Wnts, FGFs, and retinoic acid
(review in Aybar and Mayor, 2002; Aybar et al., 2002). As
Sox10 is expressed in the prospective neural crest, we de-
cided to analyze whether it was induced by FGF and Wnts.
We blocked FGF activity by using a soluble inhibitor of the
FGF receptor named SU5402, which binds to the FGF
receptor and blocks its activity (Streit et al., 2000). Beads
soaked with SU5402 were implanted next to the prospective
neural crest of a stage 12.5 embryo (Fig. 8A). Controls were
performed to show that no effect on mesodermal or neural
plate development was produced under these treatments. No
effect on the expression of the mesodermal marker Xbra or
the neural plate marker Sox2 was observed (not shown).
Embryos were fixed at stage 18 and the expression of Sox10
was analyzed by in situ hybridization. A strong inhibition in
the expression of Sox10 was observed in the side that
received the bead (Fig. 8B; 68% of inhibition, n  48). In
order to analyze the role of Wnts on Sox10 expression,
embryos at the two-cell stage were injected into one blas-
tomere with 1 ng of the mRNA that codes for a dominant
negative of Wnt8 (Hoppler et al., 1996). The embryos were
fixed at stage 20 and the expression of Sox10 was analyzed
by in situ hybridization. An inhibition of Sox10 expression
was observed in the injected side (Fig. 8C, 38% of inhibi-
tion, n  40). Thus, Wnts and FGF are required to induce
Sox10 expression in neural crest cells.
Several transcription factors have been found to be ex-
pressed in the prospective neural crest cell during the early
neurula stage (Snail, Zic5, Slug, FoxD3, etc). However, the
hierarchical relationship between these factors is not
known. One of the factors, that has been described as key
regulator of the neural crest, is Slug (Carl et al., 1999;
LaBonne and Bronner-Fraser, 2000; Mayor et al., 2000).
However, it has been shown that Slug is downstream of
Snail, and that this gene seems to be one of the earliest
genes in the genetic cascade of neural crest specification
(Aybar et al., 2003). We decided to analyze whether the
Snail or Slug gene was controlling Sox10 expression. Em-
bryos were injected in one blastomere of a two-cell-stage
embryo with 0.7 ng of the mRNA that codes for the induc-
ible form of a dominant negative of Snail, a dominant
negative of Slug, and the inducible form of the Snail and
Slug genes (Aybar et al., 2003). The embryos were treated
with dexamethasone at stage 12 to activate the inducible
constructs and cultured until stage 18, when the expression
of Sox10 was analyzed by in situ hybridization. The Snail
and Slug dominant negative produced an inhibition of Sox10
expression in the injected side, with the effect of Snail being
much stronger than Slug [Fig. 8D and F; 68% (n  39) and
55% (n  35) of inhibition, respectively]. The injection of
wild type Snail mRNA induced an expansion in the region
that expresses Sox10 (Fig. 8E, 72% of embryos with expan-
sion, n  48), while the injection of wild type Slug mRNA
produced a very small effect on Sox10 expression (not
shown). It is known that the dominant negative of Slug
affects the expression of Snail, and, in consequence, all the
genes regulated by Snail are affected by the dominant neg-
ative of Slug as well (Aybar et al., 2003). Thus, our results
indicate that Sox10 expression is mainly regulated by Snail
activity in the neural crest.
Discussion
We report here the isolation of the Xenopus Sox10 gene,
which is expressed in the prospective neural crest and in the
otic placode during development from the early neurula
stage. Loss-of-function experiments using a morpholino
(Heasman et al., 2000) that specifically blocks Sox10 activ-
ity show that Sox10 plays an important role in the early
development of the crest precursors as well as on the de-
velopment of some of the crest derivatives. We show that
Sox10 is required for the proper development of melano-
cytes and ganglia. Our results support the notion that Sox10
activity plays a role in early specification of the neural crest
cells as well as on the survival of the crest precursors.
Between 15 and 20 different Sox proteins have already
been identified in both mouse and human, and it can be
assumed that the number of Sox proteins in any given
vertebrate species will be higher than 20. Given this high
number, it is not surprising that most tissues and cell types
express a Sox protein during at least some stage of their
development (for review, see Wegner, 1999). At least 10
Sox genes have been identified in Xenopus. They are Sox2
(Mizuseki et al., 1998a), Sox3 (Penzel et al., 1997; Koyano
et al., 1997; Sakai et al., 1997), SoxD (Mizuseki et al.,
1998b), Sox7 (Shiozawa et al., 1996), XLS13A and 13B
(Hiraoka et al., 1997), Sox9 (Spokony et al., 2002), Sox12
(Komatsu et al., 1996), and Sox17 and  (Hudson et al.,
1997). Among them Sox2, Sox3, and SoxD are expressed in
the prospective neuroectoderm. SoxD has been shown to
induce neural tissue and proposed as a mediator of neural
induction, while Sox2 is not able to neuralize ectoderm but
it seems to give the ectoderm the competence to respond to
bFGF (Mizuseki et al., 1998a,b; Streit et al., 1997). The
expression of dominant negatives for Sox2 and SoxD re-
sulted in inhibition of neural plate and neural crest markers
(Mizuseki et al., 1998b; Kishi et al., 2000; Sasai et al.,
2001). However, as these dominant negatives were made by
deleting the DNA binding domain of the Sox genes, it
cannot be ruled out that these dominant negatives could
interfere with other members of the Sox family by compet-
ing for a similar partner molecule which is involved in
neural crest development. Recently, Sox9 has been identi-
fied as a new Sox gene in Xenopus. This factor is expressed
in the prospective premigratory neural crest as well as in the
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migratory cephalic crest. A loss-of-function experiment of
Sox9 shows that it is required for the specification of the
neural crest cells, and its function is particularly important
in the development of the cephalic neural crest and its
derivatives as cranial skeletal elements (Spokony et al.,
2002); in addition, embryos depleted of Sox9 activity show
a normal development of pigment cells.
The Sox10 factor, first cloned from rat glial cells, is
expressed in precursors of the peripheral nervous system
(Kulhbrodt et al., 1998). Sox10 mutations have been found
in the same cases as Type 4 Waardenburg syndrome (Pin-
gault et al., 1998, 2002), a condition associating agangli-
onosis (Hirschprung disease) and depigmentation with deaf-
ness (Waardenburg syndrome). It has been proposed that the
Sox10 gene could be involved in regulatory and signaling
pathways for the early development of the neural crest
lineages which differentiate into melanocytes and enteric
ganglia. The involvement of Sox10 in the development of
the enteric neurons has also been reported in the Dom
(Dominant megacolon) mouse model of Hirschprung’s dis-
ease. It was shown that a single base insertion in the mouse
Sox10 gene was responsible for the megacolon phenotype of
the Dom mutant (Southard et al., 1998; Herbarth et al.,
1998). In addition, it has been shown that Sox10 is ex-
pressed in the nervous system of human, mouse, and ze-
brafish during development and in some of neural crest
derivatives, such as melanocytes, peripheral glia, and cells
of the enteric nervous system (British et al., 2001; Kuhl-
brodt et al., 1998; Bondurand et al., 1998; Pusch et al.,
1998; Southard-Smith et al., 1998; Dutton et al., 2001).
Expression of Sox10 can be detected in all neural crest cells
when they are generated and is maintained in several lin-
eages later in development or up to adulthood. Thus, mu-
tations of Sox10 could produce effects at any time when this
gene is normally expressed, from the early neural crest
precursor stage until the crest derivatives have differenti-
ated. It has been shown that Sox10 is a key regulator of
peripheral glia development and differentiation of the ma-
ture glial (Wegner, 2000; Kulhbrodt et al., 1998; British et
al., 2001; Paratore et al., 2001). Thus, the characteristic
depigmentation and deafness associated with the Waarden-
burg syndrome have been explained as a failure in the
development of the melanocytes and some neural crest cells
that migrate into the ear (Watanabe et al., 2000), while the
aganglionosis observed in the Hirschprung’s disease could
be explained by a defect in the neural crest that gives rise to
the ganglia of the peripheral nervous system or directly to a
problem in maintaining the differentiated state of the cells
from the ganglia.
Our results show that Sox10 activity is required from the
earliest stage of neural crest specification. Sox10-depleted
embryos exhibited an inhibition in the expression of all
neural crest markers tested. However, we also show that
Sox10 depletion produces an increase in apoptosis and an
inhibition of cell proliferation in the neural folds. Similar
effects on apoptosis in Sox10 mutants have been described
for tissues derived form neural crest cells in mice and
zebrafish, such as the dorsal root ganglia and lateral line
ganglia (Dutton et al., 2001; Sonnenberg-Riethmacher,
2001). It was shown in zebrafish that, in the Sox10 mutant
cls, an increase in apoptosis could be starting from 40 h
postfertilization onwards, once the neural crest had com-
pleted its migration (Dutton et al., 2001); and in the Dom
mutant, the increase in apoptosis and reduction in cell pro-
liferation were detected only at 10 dpc in the dorsal root
ganglia (Sonnenberg-Riethmacher, 2001). Thus, a possible
explanation for the absence of neural crest markers in the
depleted Sox10 embryos is that one of the normal functions
of Sox10 is to act as a survival factor, and that in absence of
their activity, the crest cells die by apoptosis and its prolif-
eration is inhibited, and in consequence the expression of all
neural crest markers is inhibited or lost because the cells
that express them are absent from the embryo. However, not
all the effects of Sox10 depletion can be explained as a loss
in the crest precursors. The inhibition of early neural crest
markers, such as Slug and FoxD3, which have been in-
volved in early neural crest specification (LaBonne and
Bronner-Fraser, 2000; Mayor et al., 2000; Sasai et al.,
2001), suggests that Sox10 also plays a role on early neural
crest specification. In addition, our results show that the
reduction of the neural crest territory takes place with a
compensatory enlargement of the neural plate that is at the
border of the neural folds. This suggests that inhibition of
Sox10 activity in the folds leads to a transformation of those
cells into neural cells. This early function of Sox10 is com-
patible with the early expression found in the neural folds.
We propose here that this specification and survival activity
of Sox10 are important for neural crest development begin-
ning at embryonic stages, much earlier that was previously
proposed, even from the prospective neural crest at the
neural fold stage, before its migration. Taken together, our
results favor a double early role of Sox10 during crest
development: specification and survival of crest cells. Al-
though some of the deficiencies found in the Waardenburg
syndrome and in the Hirschprung disease could be associ-
ated with a failure of the development of crest derivatives
during the late phase of its development, or even during
adulthood, our results suggest that an earlier failure of the
precursors of the crest cells is produced by an inhibition of
Sox10 activity. Thus, Sox10 mutations could produce a
failure in neural crest derivatives by a combination of early
and late Sox10 functions. Finally, the deafness associated
with the Hirschprung’s disease could be also be dependent
on an early function of Sox10 on ear development as its
expression can be detected very early in the precursors of
the ear placode.
We have found a defect in the development of melano-
cyte and ganglia that are originated from the trunk neural
crest in our Sox10 antisense experiments. This is coherent
with the previous function attributed to Sox10 in human,
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mouse, and zebrafish. On the other hand, Sox9 depletion
leads to an inhibition of cranial skeletal development with
no effect on melanocyte development (Spokony et al.,
2002). These observations support the notion that several
members of the Sox family are involved in the development
of specific subsets of neural crest cells along the anterior–
posterior axis. Thus, Sox9 could be involved in the devel-
opment of the cephalic neural crest, while Sox10 is involved
in the development of trunk neural crest cells. However, an
intriguing observation is that both genes are coexpressed
along the entire anteroposterior axis of the neural crest in
Xenopus (Spokony et al., 2002; this work). A possible
explanation for this observation is that, although both genes
are coexpressed in the complete neural crest territory, they
have some redundant functions in some regions, with the
function of Sox9 being more important in cephalic crest, and
Sox10 in trunk neural crest. However, it is not possible to
exclude the possibility that the antisense morpholino does
not last until a late stage when melanocytes and cartilages
were analyzed (Spokony et al., 2002; this work).
Our Sox10 overexpression experiments showed a small
enlargement in neural crest markers. This small effect of
Sox10 could be explained by the fact that the Sox proteins
are known to regulate their specific target genes through
interactions with cell-specific partner factors (Kamachi et
al., 2000; Wilson and Koopman, 2002). It has been shown
that one of these such factors that interacts with Sox10 is
Pax3 (Boundurand et al., 2000; Potterf et al., 2000; Lang et
al., 2000). This interaction is required to control the tran-
scription of Mitf (Hughes et al., 1993; Hodgkinson et al.,
1993) and c-ret (Romeo et al., 1994; Edery et al., 1994).
Interestingly, Pax3 is expressed in Xenopus at the neural
plate border in a domain slightly broader than Sox10 (Bang
et al., 1999); thus, the expansion of neural crest markers on
Sox10 mRNA injection could indicate the domain where the
injected Sox10 could interact with Pax3 in the ectoderm.
Overexpression experiments coinjecting Pax3 and Sox10
could induce a larger expansion of neural crest markers.
Once we observed that Sox10 gene is expressed in the
neural crest and that it plays an important function in the
development of those cells, we become interested in under-
standing how the expression of this gene is regulated. It has
been shown that BMPs, Wnts, FGFs, and retinoic acid play
important roles in neural crest induction. Levels of BMP
intermediate to those required to induce neural plate or
epidermis have been shown to induce neural crest in Xeno-
Fig. 7. Sox10 controls melanocyte development. (A) Neural crest was
induced in vitro by conjugating animal caps taken from embryos injected
with noggin and Wnt5A mRNA. The conjugates were cultured in vitro
until the equivalent of stage 21, when several neural crest markers were
analyzed by RT-PCR. The expression of histone 4 (H4) was used as a
loading control. (B) RT-PCR performed in control conjugates. Note the
expression of all neural crest markers analyzed in the conjugates and in the
whole embryo. (C) RT-PCR performed in moSox10 conjugates. Morpho-
linos were injected in both animal caps. Note that in conjugates only the
early neural crest markers are expressed (Twist, Snail, Sox10), while the
expression of markers for the melanogenic and gangliogenic lineages are
inhibited (Mitf, c-kit, c-ret). (D) Analysis of melanocyte formation in
control embryos at stage 38. Note the normal melanocytes (arrow and
inset). (E) Analysis of melanocyte formation in embryos injected with 10
ng of moSox10 mRNA. Note the inhibition in melanocyte development
(stage 38). (F) Induction of melanocytes in vitro by conjugating an animal
cap taken from a stage 9 embryo with the prospective paraxial mesoderm
taken from a stage 10 embryo, conjugated and cultured until the equivalent
of stage 40. (G) Conjugate performed with a control animal cap, where the
melanocytes were produced normally (arrows). (H) Conjugates performed
using an animal cap taken from an embryo injected with 7 ng of moSox10
mRNA. Note the absence of melanocytes in the conjugate. Embryos in (A)
and (F) were adapted from Nieuwkoop and Faber (1967).
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pus and zebrafish (Morgan and Sargent, 1997; Marchant et
al., 1998; LaBonne and Bronner-Fraser, 1998; Nguyen et
al., 1998; Villanueva et al., 2002). FGF has also been
implicated in neural crest induction (Mayor et al., 1995;
1997; LaBonne and Bronner-Fraser, 1998; Villanueva et al.,
2002). The role of FGF is nonetheless controversial as it has
been implicated in neural plate induction (Launay et al.,
1996). However, in Xenopus, the direct participation of FGF
in neural plate induction is less likely (Holowacz and Sokol,
1999; Ribisi et al., 2000; Curran and Grainger, 2000). Wnt
and some elements of the Wnts signaling pathway have also
been involved in neural crest induction (Saint- Jeannet et al.,
1997; LaBonne and Bronner-Fraser, 1998; Chang and Hem-
mati-Brivanlou, 1998). Thus, we decided to test whether
FGF and Wnts were also involved in the induction of Sox10.
Our results, using an inhibitor of FGF activity and a dom-
inant negative of Wnt8, show that both signaling pathways
are required for Sox10 induction, which is compatible with
the role of these molecules in the induction of neural crest.
The inhibition of FGF and Wnt signaling could also affect
the posteriorizing activity of these factors, which has been
proposed to be involved in neural crest specification (Vil-
lanueva et al., 2002). In addition, we observed that the
expression of Sox10 in the otic vesicle was also affected
when FGF or Wnt8 activity was perturbed. These results
suggest that the same molecular mechanism that induces
neural crest could be important to specify the placode re-
gion.
The complex sequence of inductive events responsible
for the generation of neural crest at the border between the
Fig. 8. Regulation of Sox10 expression by extracellular signals and by transcription factors. (A) A bead soaked with the FGF inhibitor SU5402 was grafted
into the right side of a stage 12.5 embryo, next to the prospective neural crest. The embryos were cultured until stage 18, when the expression of Sox10 was
analyzed by in situ hybridization. Figure adapted from Nieuwkoop and Faber (1967). (B) Note the absence of Sox10 expression in the prospective neural crest
and otic placode in the side that received the bead. (C) Embryos were injected in one blastomere at the two-cell stage with 1 ng of mRNA that encodes a
dominant negative of Wnt8. The embryos were cultured until stage 20, and the expression of Sox10 was analyzed by in situ hybridization. Note the inhibition
in the expression of Sox10. (D) Embryos were injected in one blastomere at the two-cell stage with 0.7 ng of mRNA that encodes an inducible form of a
dominant negative of Snail. The embryos were treated with dexometasone at stage 12, and the expression of Sox10 was analyzed by in situ hybridization
at stage 18. Note the inhibition in the expression of Sox10. (E) Embryos were injected in one blastomere at the two- cell stage with 0.7 ng of mRNA that
encodes an inducible form of the Snail gene. The embryos were treated with dexometasone at stage 12, and the expression of Sox10 was analyzed by in situ
hybridization at stage 18. Note the expansion in the expression of Sox10. (F) Embryos were injected in one blastomere at the two-cell stage with 0.7 ng of
mRNA that encodes an inducible form of a dominant negative of Slug. The embryos were treated with dexometasone at stage 12, and the expression of Sox10
was analyzed by in situ hybridization at stage 18. Note the inhibition in the expression of Sox10.
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neural plate and the epidermis triggers a genetic cascade
involving several families of transcription factors. Some of
the genes that have been involved in this cascade are Snail
(Mayor et al., 1993; Essex et al., 1993; Aybar et al., 2003),
Slug (Nieto et al., 1994; Mayor et al., 1995; Carl et al.,
1999; Labonne and Bronner-Fraser, 2000; Mayor et al.,
2000; Del Barrio and Nieto, 2002), Zic5 (Nakata et al.,
1998, 2000), and FoxD3 (Sasai et al., 2001). It has been
shown that Snail is able to induce the expression of Slug and
all other neural crest markers tested (Zic5, FoxD3, Twist,
and Ets1) at the time of specification. This activation was
observed in whole embryos and in animal caps, in the
absence of neural plate and mesodermal markers, which
indicates that Snail lies upstream of Slug in the genetic
cascade leading to neural crest formation and that it plays a
key role in crest development (Aybar et al., 2003). Accord-
ing to this, we analyzed whether Snail and Slug were also
controlling the transcription of Sox10. Our results using
inducible dominant negatives and the wild type genes show
that Snail is able to control Sox10 expression. However, the
overexpression of Slug was not able to upregulate Sox10
expression. Taken together, these results indicate that Sox10
lies in between Snail and Slug in the genetic cascade that
controls neural crest development.
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